Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic

Roger E Peverill1, Bon Chou1, Lesley Donelan1

  • 1Monash Cardiovascular Research Centre, MonashHeart and Department of Medicine, School of Clinical Sciences at Monash Health, Monash University and Monash Health, Clayton, Victoria, Australia.

Plos One
|October 7, 2020
PubMed

Insights

In hypertrophic cardiomyopathy (HCM), reduced left ventricular (LV) longitudinal contraction limits early diastolic motion. This, along with prolonged early diastolic motion, lowers early diastolic mitral annular velocity (e`).

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Echocardiography

Background:

  • Early diastolic mitral annular velocity (e`) is a key indicator of left ventricular (LV) diastolic dysfunction in hypertrophic cardiomyopathy (HCM).
  • Other aspects of LV long-axis function in HCM, including systolic excursion (SExc) and early diastolic excursion (EDExc), are less understood.
  • The impact of HCM on atrial contraction excursion (AExc) and early diastolic motion duration (EDDur) remains unclear.

Purpose of the Study:

  • To investigate the effects of HCM on various parameters of LV long-axis function during diastole.
  • To explore the relationships between systolic and diastolic mitral annular excursion and early diastolic velocity.
  • To identify independent predictors of early diastolic mitral annular excursion and velocity in HCM.

Main Methods:

  • Compared 22 subjects with HCM to 22 age- and sex-matched controls.
  • Measured SExc, EDExc, e`, AExc, and EDDur using pulsed wave tissue Doppler imaging of septal and lateral walls.
  • Utilized multivariate regression analyses to identify predictors of EDExc and e`.

Main Results:

  • HCM group showed lower SExc, EDExc, and e`, and longer EDDur compared to controls (p<0.05).
  • Septal AExc was lower in HCM, but lateral AExc was not significantly different.
  • SExc strongly predicted EDExc (57-86% variance), and EDExc (with EDDur) strongly predicted e` (58-92% variance).

Conclusions:

  • Reduced LV longitudinal contraction is the primary cause of decreased EDExc in HCM.
  • Lower e` in HCM results from reduced EDExc and prolonged early diastolic motion.
  • Atrial contraction does not compensate for the impaired longitudinal function in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
231
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
502
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
270
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
220
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
242
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176